decaro

HGEN: log chart of a COVID-related trade

NASDAQ:HGEN   None
Humanigen is due to present major data from Phase III trials at three conferences in mid-March. The stock is in multiple wedges, and a breakout or breakdown seems highly likely.

Shares are currently trending sideways --- in my opinion, as investors await the outcomes of these events.

When it comes, the move is likely to be explosive. Thus, implied volatility is presently quite high. Normally, I would be tempted to sell a straddle. But I think that realized volatility may exceed implied volatility in this case. Just a guess!

I am buying long ATM straddles here with the April 16 expiration. I am also buying shares of the stock on this week's pullback.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。